SPX3,951.09-12.85 -0.32%
DIA338.18-0.31 -0.09%
IXIC10,973.50-76.00 -0.69%

Reported Late Tuesday, Burning Rock Biotech Q3 EPS $(0.31) Beats $(0.32) Estimate, Sales $21.74M Beat $21.15M Estimate

Benzinga · 11/16/2022 01:07
Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.32) by 3.13 percent. This is a 24 percent decrease over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $21.74 million which beat the analyst consensus estimate of $21.15 million by 2.78 percent. This is a 10.63 percent increase over sales of $19.65 million the same period last year.